These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11739913)

  • 1. Med-psych drug-drug interactions update.
    Armstrong SC; Cozza KL
    Psychosomatics; 2001; 42(5):435-7. PubMed ID: 11739913
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ziprasidone. A new second-generation antipsychotic agent].
    Lublin HK
    Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic Malignant Syndrome with ziprasidone.
    Murty RG; Mistry SG; Chacko RC
    J Clin Psychopharmacol; 2002 Dec; 22(6):624-6. PubMed ID: 12454565
    [No Abstract]   [Full Text] [Related]  

  • 4. What can large simple trials do for psychiatry?
    Stroup TS
    Am J Psychiatry; 2011 Feb; 168(2):117-9. PubMed ID: 21297045
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract]   [Full Text] [Related]  

  • 6. QT interval--what is normal? Comment on "single-dose ziprasidone associated with QT interval prolongation".
    Sanaei-Zadeh H
    Am J Emerg Med; 2012 May; 30(4):627. PubMed ID: 22306388
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerability of ziprasidone: an expanding perspective.
    Daniel DG
    J Clin Psychiatry; 2003; 64 Suppl 19():40-9. PubMed ID: 14728089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study.
    Vieweg WV; Hasnain M
    Am J Psychiatry; 2011 Jun; 168(6):650-1; author reply 651. PubMed ID: 21642483
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 10. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
    Bentley ML; Biscardi FH; Butcher C; Levitov A
    Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
    [No Abstract]   [Full Text] [Related]  

  • 11. Bipolar therapeutics update 2014: A tale of 3 treatments.
    Ketter TA; Wang PW; Miller S
    J Clin Psychiatry; 2015 Jan; 76(1):69-70. PubMed ID: 25650673
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug safety evaluation of ziprasidone.
    Citrome L
    Expert Opin Drug Saf; 2011 May; 10(3):437-48. PubMed ID: 21332416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
    den Boon FS; Body S; Hampson CL; Bradshaw CM; Szabadi E; de Bruin N
    J Psychopharmacol; 2012 Sep; 26(9):1231-43. PubMed ID: 21969105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ziprasidone and dementia].
    Aakhus E
    Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2155-6; author reply 2155-6. PubMed ID: 15334150
    [No Abstract]   [Full Text] [Related]  

  • 15. Ziprasidone and migraine headache.
    Boeker T
    Am J Psychiatry; 2002 Aug; 159(8):1435-6. PubMed ID: 12153843
    [No Abstract]   [Full Text] [Related]  

  • 16. Focus on ziprasidone.
    Green B
    Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone: a novel psychotropic with unique properties.
    Ballas C; Yang C; O'Reardon J; Ballas P; Baldassano C
    Expert Rev Neurother; 2004 Mar; 4(2):179-86. PubMed ID: 15853558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.